Clinical trial shows liver patients see benefits after going meatless for one meal

  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 46 sec. here
  • 7 min. at publisher
  • 📊 Quality Score:
  • News: 39%
  • Publisher: 51%

Medicine Research News News

Medicine Research,Health Research News,Health Research

Just one meal without meat can lower levels of harmful ammonia in people with advanced liver disease, researchers from Virginia Commonwealth University's School of Medicine and Richmond VA Medical Center report.

Clinical trial shows liver patients see benefits after going meatless for one meal retrieved 2 May 2024 from https://medicalxpress.com/news/2024-05-clinical-trial-liver-patients-benefits.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.21 hours ago Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.

Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 101. in LAW

Law Law Latest News, Law Law Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in clinical trialResearchers at Texas Children's Cancer Center and the Center for Cell and Gene Therapy at Baylor College of Medicine, Texas Children's Hospital and Houston Methodist have published results of a Phase I clinical trial of a novel immunotherapy for high-risk sarcomas in the journal Nature Cancer.
Source: medical_xpress - 🏆 101. / 51 Read more »

First clinical trial of vosoritide for children with hypochondroplasia shows increased growthThe first clinical trial of vosoritide for children with hypochondroplasia has shown increased growth. The trial, conducted by researchers, involved children aged 5 to 14 years with hypochondroplasia, a rare genetic disorder that causes short stature.
Source: medical_xpress - 🏆 101. / 51 Read more »

Clinical trial evaluates azithromycin for preventing chronic lung disease in premature babiesThe early use of azithromycin does not prevent the development of chronic lung disease in premature babies, finds new research by Cardiff University.
Source: medical_xpress - 🏆 101. / 51 Read more »

Researchers publish final results of key clinical trial for gene therapy for sickle cell diseaseIn a landmark study, an international consortium led by researchers at Children's Hospital of Philadelphia (CHOP) published the final results of a key clinical trial of the gene therapy CASGEVY (exagamglogene autotemcel) for the treatment of sickle cell disease in patients 12 years and older with recurrent vaso-occlusive crises (VOCs).
Source: medical_xpress - 🏆 101. / 51 Read more »

New sleep-enhancing nutraceutical blend falls short in clinical trialStudy investigates the impact of a unique nutraceutical blend, combining L-theanine with valerian, saffron, and lemon balm extracts, on improving sleep quality, finding no significant difference compared to a placebo in individuals experiencing poor sleep.
Source: NewsMedical - 🏆 19. / 71 Read more »

Preventive ablation of ventricular tachycardia avoids shocks and hospitalization, finds clinical trialThe first randomized trial to investigate preventive ablation of a potential arrhythmogenic substrate associated with coronary chronic total occlusion (CTO) in patients at high risk of ventricular arrhythmias (VAs) reduces the risk of appropriate implantable cardioverter-defibrillator (ICD) therapy and unplanned hospitalization in patients with no...
Source: medical_xpress - 🏆 101. / 51 Read more »